argenx SE | Investor Presentation Deck | 22 slides · page 14 of 22
The slide highlights the mechanism of action (sweeping antibody) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.
Conference presentation · key_messages · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 image 1/1 list 1/1 title 1/1
Components 4
primary illustration bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.